Medicare billing address
CMS Medicare provider billing file
2112 Providence AveChester, PA 19013
CMS public data · NPI 1205917820
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Joel R Perloff, MD
Specialty
Credential
MD
NPI
1205917820
Primary source state
PA
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Joel R Perloff, MD from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
2112 Providence AveCMS Doctors & Clinicians file
1098 W Baltimore PikeCMS Doctors & Clinicians file
2112 Providence AveIn the 2024 CMS provider billing file, this NPI had 1,032 Medicare beneficiaries and 4,082 total services. The average beneficiary age was 74, and the average HCC risk score was 1.1.
Total Medicare allowed amount
$328,927.62
Total Medicare payment amount
$233,929.96
Medicare beneficiaries
1,032
Total services
4,082
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
70%
CMS beneficiary-panel share
Anxiety
28%
CMS beneficiary-panel share
Diabetes
26%
CMS beneficiary-panel share
Ischemic heart disease
25%
CMS beneficiary-panel share
Mood disorders
24%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Professional service for preparation and provision of 1 or more antigens | 1,020 | $13.56 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 597 | $124.81 |
| Removal of impacted ear wax | 366 | $42.48 |
| New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 366 | $163.44 |
| Diagnostic exam of voice box using a flexible endoscope | 263 | $125.48 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 223 | $87.57 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 216 | $49.33 |
| Test to assess middle ear function | 179 | $15.86 |
| Comprehensive hearing and speech recognition test | 168 | $35.19 |
| Diagnostic exam of nasal passages using an endoscope | 136 | $182.38 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1205917820. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Fluticasone Propionate | Fluticasone Propionate | 160 | 381.2 | $3,411.42 |
| 2 | Omeprazole | Omeprazole | 146 | 420.3 | $1,596.56 |
| 3 | Famotidine | Famotidine | 145 | 385 | $2,540.38 |
| 4 | Prednisone | Prednisone | 113 | 115 | $313.93 |
| 5 | Ipratropium Bromide | Ipratropium Bromide | 112 | 257.9 | $4,956.27 |
| 6 | Mupirocin | Mupirocin | 57 | 57 | $310.66 |
| 7 | Azelastine Hcl | Azelastine Hcl | 43 | 96.4 | $1,759.37 |
| 8 | Ciprofloxacin-Dexamethasone | Ciprofloxacin Hcl/Dexameth | 40 | 40 | $4,498.09 |
| 9 | Montelukast Sodium | Montelukast Sodium | 32 | 76 | $319.87 |
| 10 | Amoxicillin | Amoxicillin | 28 | 28 | $90.04 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Graduation year
1999
Group/practice field
Providence Ear Nose And Throat Associates Inc
Telehealth reported
Not reported
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.